Johan A. van Zyl
No más puestos en curso
Perfil
Johan A.
van Zyl served as a Director-Supervisory Board at Bac BV.
Prior to that, he worked as a Deal Manager at Stonehage Fleming Private Equity Ltd.
from 2001 to 2009.
He completed his undergraduate degree from the University of Stellenbosch.
Antiguos cargos conocidos de Johan A. van Zyl.
| Empresas | Cargo | Fin |
|---|---|---|
Stonehage Fleming Private Equity Ltd.
 Stonehage Fleming Private Equity Ltd. Investment ManagersFinance Stonehage Fleming Private Equity Ltd (Stonehage Fleming Private Equity) is a private equity subsidiary of Stonehage Fleming (UK) Ltd founded in 2000. The firm is headquartered in London, United Kingdom. | Inversor de Capital Privado | 01/12/2009 |
BAC BV
 BAC BV Industrial MachineryProducer Manufacturing BAC BV discovers, develops and manufactures affinity ligands and affinity purification products for the biopharmaceutical market. Its CaptureSelect products are used for drug discovery up to manufacturing of biopharmaceuticals and are based on a proprietary platform technology, integrating affinity ligand discovery, manufacturing and immobilization of single domain antibodies derived from Camelids. The company was founded in 1995 and is headquartered in Amsterdam, the Netherlands. | Director/Miembro de la Junta | - |
Formación de Johan A. van Zyl.
| University of Stellenbosch | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 2 |
|---|---|
Stonehage Fleming Private Equity Ltd.
Stonehage Fleming Private Equity Ltd. Investment ManagersFinance Stonehage Fleming Private Equity Ltd (Stonehage Fleming Private Equity) is a private equity subsidiary of Stonehage Fleming (UK) Ltd founded in 2000. The firm is headquartered in London, United Kingdom. | Finance |
BAC BV
BAC BV Industrial MachineryProducer Manufacturing BAC BV discovers, develops and manufactures affinity ligands and affinity purification products for the biopharmaceutical market. Its CaptureSelect products are used for drug discovery up to manufacturing of biopharmaceuticals and are based on a proprietary platform technology, integrating affinity ligand discovery, manufacturing and immobilization of single domain antibodies derived from Camelids. The company was founded in 1995 and is headquartered in Amsterdam, the Netherlands. | Producer Manufacturing |
- Bolsa de valores
- Insiders
- Johan A. van Zyl
